✦ LIBER ✦

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials

✍ Scribed by Gilcin F. Meadors III; Paul H. Gibbs; C.J. Peters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of an inactiva

✍ Janice M. Rusnak; Paul Gibbs; Ellen Boudreau; Denise P. Clizbe; Phillip Pittman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Safety and immunogenicity of recombinant

✍ John C. Morrill; Richard C. Laughlin; Nandadeva Lokugamage; Roberta Pugh; Elena 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 454 KB

Immunogenicity and efficacy of a chimpan

✍ Warimwe, George M; Lorenzo, Gema; Lopez-Gil, Elena; Reyes-Sandoval, Arturo; Cott 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 599 KB

Immunogenicity of an inactivated Rift Va

✍ Phillip R. Pittman; C.T. Liu; Timothy L. Cannon; Richard S. Makuch; Joseph A. Ma 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Evaluation of the efficacy and safety of

✍ Baptiste Dungu; Ian Louw; Alison Lubisi; Pamela Hunter; Beate F. von Teichman; M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Further evaluation of a mutagen-attenuat

✍ J.C. Morrill; L. Carpenter; D. Taylor; H.H. Ramsburg; J. Quance; C.J. Peters 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 802 KB